Clinical Applications of Metabolomics in Oncology: A Review
- 15 January 2009
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (2), 431-440
- https://doi.org/10.1158/1078-0432.ccr-08-1059
Abstract
Metabolomics, an omic science in systems biology, is the global quantitative assessment of endogenous metabolites within a biological system. Either individually or grouped as a metabolomic profile, detection of metabolites is carried out in cells, tissues, or biofluids by either nuclear magnetic resonance spectroscopy or mass spectrometry. There is potential for the metabolome to have a multitude of uses in oncology, including the early detection and diagnosis of cancer and as both a predictive and pharmacodynamic marker of drug effect. Despite this, there is lack of knowledge in the oncology community regarding metabolomics and confusion about its methodologic processes, technical challenges, and clinical applications. Metabolomics, when used as a translational research tool, can provide a link between the laboratory and clinic, particularly because metabolic and molecular imaging technologies, such as positron emission tomography and magnetic resonance spectroscopic imaging, enable the discrimination of metabolic markers noninvasively in vivo. Here, we review the current and potential applications of metabolomics, focusing on its use as a biomarker for cancer diagnosis, prognosis, and therapeutic evaluation.Keywords
This publication has 99 references indexed in Scilit:
- Data Mining in GenomicsClinics in Laboratory Medicine, 2008
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib SensitivityGastroenterology, 2006
- Citrate Concentrations in Human Seminal Fluid and Expressed Prostatic Fluid Determined via 1H Nuclear Magnetic Resonance Spectroscopy Outperform Prostate Specific Antigen in Prostate Cancer DetectionJournal of Urology, 2006
- Metabolomics: The Greatest Omics of Them All?Analytical Chemistry, 2006
- MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone statusBreast Cancer Research and Treatment, 2006
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parametersNMR in Biomedicine, 2005
- Metabolic Profiling Allows Comprehensive Phenotyping of Genetically or Environmentally Modified Plant SystemsTHE PLANT CELL ONLINE, 2001
- Detection of Malignant TumorsThe New England Journal of Medicine, 1986